These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37865603)

  • 1. Stereotactic body radiation therapy for liver metastases in oligometastatic disease.
    Jaksic N; Modesto A; Meillan N; Bordron A; Michalet M; Riou O; Lisbona A; Huguet F
    Cancer Radiother; 2024 Feb; 28(1):75-82. PubMed ID: 37865603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
    Robin TP; Raben D; Schefter TE
    Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancer.
    Py JF; Salleron J; Courrech F; Beckendorf V; Croisé-Laurent V; Peiffert D; Vogin G; Dietmann AS
    Cancer Radiother; 2021 Jun; 25(4):350-357. PubMed ID: 33618909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases.
    Lee SL; Bassetti MF; Rusthoven CG
    Semin Radiat Oncol; 2023 Apr; 33(2):181-192. PubMed ID: 36990635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stereotactic body radiotherapy for liver tumors: State of the art].
    Riou O; Azria D; Mornex F
    Cancer Radiother; 2017 Oct; 21(6-7):563-573. PubMed ID: 28888744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy.
    Wang WJ; Chiou JF; Huang Y
    J Vis Exp; 2018 May; (135):. PubMed ID: 29806826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
    Chen H; Louie AV; Higginson DS; Palma DA; Colaco R; Sahgal A
    Clin Oncol (R Coll Radiol); 2020 Nov; 32(11):713-727. PubMed ID: 32718762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for bone oligometastases.
    Naessens C; Chamois J; Supiot S; Faivre JC; Arnaud A; Thureau S
    Cancer Radiother; 2024 Feb; 28(1):111-118. PubMed ID: 37838605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
    Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
    Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
    Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
    Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
    Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
    Leduc C; Antoni D; Quoix É; Noël G
    Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of radiotherapy to the primary tumor and metastases in patients with oligometastatic prostate cancer].
    Le Roy T; Baron D; Vandendorpe B; Bataille B; Hannoun-Levi JM; Blanchard P; Lartigau E; Latorzeff I; Pasquier D
    Cancer Radiother; 2021 Oct; 25(6-7):526-532. PubMed ID: 34400086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stereotactic body radiation therapy for oligometastatic prostate cancer].
    Bibault JE
    Bull Cancer; 2018 Jan; 105(1):120-125. PubMed ID: 29191358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of stereotactic radiotherapy in the treatment of oligometastatic colorectal cancer].
    Pouypoudat C; Trouette R; Bernard B; Vendrely V
    Cancer Radiother; 2021 Oct; 25(6-7):523-525. PubMed ID: 34454836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.
    Klement RJ; Guckenberger M; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Habermehl D; Hildebrandt G; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Andratschke N
    Radiother Oncol; 2017 May; 123(2):227-233. PubMed ID: 28274491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.